NMR Experiment |
---|
Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
---|
1 | 2D 1H-15N HSQC | 1.2 mM [U-98% 13C; U-98% 15N] NmR46C, 10 % D2O, 90 % H2O, 20 mM MES, 200 mM sodium chloride, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS, 1x v/v protease inhibitors, 0.02 % sodium azide | 90% H2O/10% D2O | 430 | 6.5 | ambient | 298 | |
2 | 2D 1H-13C HSQC | 1.2 mM [U-98% 13C; U-98% 15N] NmR46C, 10 % D2O, 90 % H2O, 20 mM MES, 200 mM sodium chloride, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS, 1x v/v protease inhibitors, 0.02 % sodium azide | 90% H2O/10% D2O | 430 | 6.5 | ambient | 298 | |
3 | 2D 1H-13C HSQC | 1.2 mM [U-5% 13C; U-98% 15N] NmR46C, 10 % D2O, 90 % H2O, 20 mM MES, 200 mM sodium chloride, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS, 1x v/v protease inhibitors, 0.02 % sodium azide | 90% H2O/10% D2O | 430 | 6.5 | ambient | 298 | |
4 | 3D sim 15N,13C NOESY | 1.2 mM [U-98% 13C; U-98% 15N] NmR46C, 10 % D2O, 90 % H2O, 20 mM MES, 200 mM sodium chloride, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS, 1x v/v protease inhibitors, 0.02 % sodium azide | 90% H2O/10% D2O | 430 | 6.5 | ambient | 298 | |
5 | 3D HNCO | 1.2 mM [U-98% 13C; U-98% 15N] NmR46C, 10 % D2O, 90 % H2O, 20 mM MES, 200 mM sodium chloride, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS, 1x v/v protease inhibitors, 0.02 % sodium azide | 90% H2O/10% D2O | 430 | 6.5 | ambient | 298 | |
6 | (4,3)D HNCABCA | 1.2 mM [U-98% 13C; U-98% 15N] NmR46C, 10 % D2O, 90 % H2O, 20 mM MES, 200 mM sodium chloride, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS, 1x v/v protease inhibitors, 0.02 % sodium azide | 90% H2O/10% D2O | 430 | 6.5 | ambient | 298 | |
7 | GFT (4,3)D CABCA(CO)NH | 1.2 mM [U-98% 13C; U-98% 15N] NmR46C, 10 % D2O, 90 % H2O, 20 mM MES, 200 mM sodium chloride, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS, 1x v/v protease inhibitors, 0.02 % sodium azide | 90% H2O/10% D2O | 430 | 6.5 | ambient | 298 | |
8 | GFT (4,3)D HABCAB(CO)NH | 1.2 mM [U-98% 13C; U-98% 15N] NmR46C, 10 % D2O, 90 % H2O, 20 mM MES, 200 mM sodium chloride, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS, 1x v/v protease inhibitors, 0.02 % sodium azide | 90% H2O/10% D2O | 430 | 6.5 | ambient | 298 | |
9 | GFT (4,3)D arom. HCCH | 1.2 mM [U-98% 13C; U-98% 15N] NmR46C, 10 % D2O, 90 % H2O, 20 mM MES, 200 mM sodium chloride, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS, 1x v/v protease inhibitors, 0.02 % sodium azide | 90% H2O/10% D2O | 430 | 6.5 | ambient | 298 | |
10 | GFT (4,3)D aliph. HCCH | 1.2 mM [U-98% 13C; U-98% 15N] NmR46C, 10 % D2O, 90 % H2O, 20 mM MES, 200 mM sodium chloride, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS, 1x v/v protease inhibitors, 0.02 % sodium azide | 90% H2O/10% D2O | 430 | 6.5 | ambient | 298 | |
11 | 2D 1H-15N HSQC | 1.2 mM [U-5% 13C; U-98% 15N] NmR46C, 10 % D2O, 90 % H2O, 20 mM MES, 200 mM sodium chloride, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS, 1x v/v protease inhibitors, 0.02 % sodium azide | 90% H2O/10% D2O | 430 | 6.5 | ambient | 298 | |
12 | 2D 1H-15N TROSY | 1.2 mM [U-5% 13C; U-98% 15N] NmR46C, 10 % D2O, 90 % H2O, 20 mM MES, 200 mM sodium chloride, 5 mM calcium chloride, 10 mM DTT, 50 uM DSS, 1x v/v protease inhibitors, 0.02 % sodium azide | 90% H2O/10% D2O | 430 | 6.5 | ambient | 298 | |